Millennium Management’s Aclaris Therapeutics ACRS Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $5.45M | Sell |
3,837,380
-296,768
| -7% | -$421K | ﹤0.01% | 2023 |
|
2025
Q1 | $6.33M | Buy |
4,134,148
+2,175,101
| +111% | +$3.33M | ﹤0.01% | 1819 |
|
2024
Q4 | $4.86M | Sell |
1,959,047
-1,046,551
| -35% | -$2.6M | ﹤0.01% | 2012 |
|
2024
Q3 | $3.46M | Sell |
3,005,598
-331,252
| -10% | -$381K | ﹤0.01% | 2212 |
|
2024
Q2 | $3.67M | Buy |
3,336,850
+63,358
| +2% | +$69.7K | ﹤0.01% | 2123 |
|
2024
Q1 | $4.06M | Sell |
3,273,492
-205,869
| -6% | -$255K | ﹤0.01% | 2132 |
|
2023
Q4 | $3.65M | Buy |
3,479,361
+1,511,381
| +77% | +$1.59M | ﹤0.01% | 2098 |
|
2023
Q3 | $13.5M | Buy |
1,967,980
+1,140,896
| +138% | +$7.82M | 0.01% | 1204 |
|
2023
Q2 | $8.58M | Buy |
827,084
+766,221
| +1,259% | +$7.95M | ﹤0.01% | 1572 |
|
2023
Q1 | $492K | Sell |
60,863
-147,035
| -71% | -$1.19M | ﹤0.01% | 3434 |
|
2022
Q4 | $3.27M | Buy |
207,898
+3,993
| +2% | +$62.9K | ﹤0.01% | 2374 |
|
2022
Q3 | $3.21M | Buy |
203,905
+5,111
| +3% | +$80.4K | ﹤0.01% | 2534 |
|
2022
Q2 | $2.78M | Buy |
198,794
+142,581
| +254% | +$1.99M | ﹤0.01% | 2621 |
|
2022
Q1 | $969K | Sell |
56,213
-296,294
| -84% | -$5.11M | ﹤0.01% | 3605 |
|
2021
Q4 | $5.13M | Buy |
352,507
+31,316
| +10% | +$455K | ﹤0.01% | 2215 |
|
2021
Q3 | $5.78M | Buy |
321,191
+120,827
| +60% | +$2.17M | ﹤0.01% | 2042 |
|
2021
Q2 | $3.52M | Sell |
200,364
-142,883
| -42% | -$2.51M | ﹤0.01% | 2535 |
|
2021
Q1 | $8.65M | Buy |
343,247
+134,321
| +64% | +$3.38M | 0.01% | 1527 |
|
2020
Q4 | $1.35M | Sell |
208,926
-72,872
| -26% | -$472K | ﹤0.01% | 2732 |
|
2020
Q3 | $724 | Sell |
281,798
-103,137
| -27% | -$265 | ﹤0.01% | 2664 |
|
2020
Q2 | $624K | Buy |
+384,935
| New | +$624K | ﹤0.01% | 2624 |
|
2020
Q1 | – | Sell |
-281,848
| Closed | -$533K | – | 3096 |
|
2019
Q4 | $533K | Buy |
281,848
+21,397
| +8% | +$40.5K | ﹤0.01% | 2720 |
|
2019
Q3 | $281K | Buy |
260,451
+225,065
| +636% | +$243K | ﹤0.01% | 2987 |
|
2019
Q2 | $77K | Buy |
35,386
+14,484
| +69% | +$31.5K | ﹤0.01% | 3372 |
|
2019
Q1 | $125K | Buy |
+20,902
| New | +$125K | ﹤0.01% | 3279 |
|
2018
Q2 | – | Sell |
-110,827
| Closed | -$1.94M | – | 3373 |
|
2018
Q1 | $1.94M | Buy |
110,827
+99,029
| +839% | +$1.74M | ﹤0.01% | 2170 |
|
2017
Q4 | $291K | Buy |
+11,798
| New | +$291K | ﹤0.01% | 3132 |
|
2017
Q3 | – | Sell |
-15,092
| Closed | -$409K | – | 3198 |
|
2017
Q2 | $409K | Buy |
15,092
+5,273
| +54% | +$143K | ﹤0.01% | 2664 |
|
2017
Q1 | $293K | Buy |
+9,819
| New | +$293K | ﹤0.01% | 2824 |
|